Sub Occipital Muscle Inhibition Versus Slump Stretch Position in Short Hamstring Syndrome Subjects

January 25, 2020 updated by: Hadaya Mosaad, Jouf University

Effect of Adding Sub-occipital Muscle Inhibition Technique Versus Slump Stretch Position to Passive Hamstring Stretch on Hamstring Flexibility in Patients With Short Hamstring Syndrome

45 female participants with short hamstring syndrome were devided into one of the three groups; Group I: suboccipital muscle inhinbition plus passive hamstring stretch, group II: Slump stretch position plus Passive hamstring stretch, and group III: Passive stretch of hamstring muscle. Assessment methods were Straight leg raising test, forward flexion test and popliteal angle test, were measured at baseline, immediately after 1st treatment session then after 4 weeks of treatment.

Study Overview

Status

Completed

Detailed Description

Forty five university undergraduate female students volunteered to participate in the study, age = 18-25 years old, body mass index 18-25 kg/cm square.

All subjects were free from injury or disease expected to affect hamstring length or ability to perform the exercises Design of the study was single-blind randomized clinical trial. The subjects were randomly assigned in to one of the three methods of treatment, which are group 1 (study group1): suboccipital muscle inhibition plus passive stretch of hamstring muscle, Group II: ( Study groupII): received neural slump test position plus passive stretch of hamstring muscle, Group III (control group): received only passive stretch of hamstring muscle.

Treatment Procedures:

Passive stretching of hamstring muscle:

Patient in comfortable supine lying position and therapist stride standing beside the dominant side of the patient. The patient was asked to flex his hip joint with complete knee extension and ankle in neutral position. The therapist stretches the hamstring of the dominant side; distal hand of the therapist on planter surface of foot for dorsiflexion to increase flexibility of hamstring muscle and proximal hand on the knee to increase the length of the muscle, maintain this stretching for 60 seconds then relax (8)

Sub occipital muscle inhibition:

The Patient is in comfortable supine lying position with eye closed - for more relaxation- and the head out of the bed resting on therapist hand to manipulate the sub occipital area. The therapist stretch the sub occipital, flexes the head of the patient to get the chin to the manibiurim sternii, maintaining this position for 60seconds then relax (9)

Neural dynamic slump stretch:

Patient in comfortable short sitting position at the edge of the bed with the trunk in an millitary straight position then ask the patient to slump the flex his neck and street the knee joint in complete extension the at the end of the procedure do active dorsiflexion at the tested foot .(10)

Study Type

Interventional

Enrollment (Actual)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 0025
        • Faculty of physical therapy, Cairo University.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 26 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. Being females.
  2. Age between 18-28 years old.
  3. BMI: 18-25 kg/square meter.
  4. All subjects were free from injury or disease expected to affect hamstring length or ability to perform the exercises.
  5. Straight leg raising test (SLR) is less than 80 degree from supine position.
  6. Popliteal angle test, operationally defined by a knee flexion angle greater than 15˚ as measured by a screening exam using active knee extension in supine with hip flexed 90˚

Exclusion Criteria:

  • Hamstring injury within the past year.
  • Exceeding 80° in the initial SLR test. Popleteal knee angle less than 15 degree. -
  • Verbal report of performing regular lower extremity. Muscle stretching exercises.
  • History of neck trauma (whiplash). Neck symptoms.-
  • History of recent fracture in any part of the body.
  • History of growth disorders,

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group 1
suboccipital muscle inhibition plus passive stretch of hamstring muscle.

The patient was asked to flex his hip joint with complete knee extension and ankle in neutral position. The therapist stretches the hamstring of the dominant side; distal hand of the therapist on planter surface of foot for dorsiflexion. and proximal hand on the knee to increase the length of the muscle, maintain this stretching for 60 seconds then relax .Sub occipital muscle inhibition:

The Patient is supine, The therapist stretch the sub occipital, flexes the head of the patient to get the chin to the manibiurim sternii, maintaining this position for 60seconds then relax Slump strtch position:Patient in comfortable short sitting position at the edge of the bed with the trunk in an millitary straight position then ask the patient to slump the flex his neck and street the knee joint in complete extension the at the end of the procedure do active dorsiflexion at the tested foot

Other Names:
  • slump stretch position
  • Passive stretch of the hamstring muscle.
Experimental: Experimental group 2
Neural slump strtch position plus passive stretch of hamstring muscle.

The patient was asked to flex his hip joint with complete knee extension and ankle in neutral position. The therapist stretches the hamstring of the dominant side; distal hand of the therapist on planter surface of foot for dorsiflexion. and proximal hand on the knee to increase the length of the muscle, maintain this stretching for 60 seconds then relax .Sub occipital muscle inhibition:

The Patient is supine, The therapist stretch the sub occipital, flexes the head of the patient to get the chin to the manibiurim sternii, maintaining this position for 60seconds then relax Slump strtch position:Patient in comfortable short sitting position at the edge of the bed with the trunk in an millitary straight position then ask the patient to slump the flex his neck and street the knee joint in complete extension the at the end of the procedure do active dorsiflexion at the tested foot

Other Names:
  • slump stretch position
  • Passive stretch of the hamstring muscle.
Active Comparator: Control group
passive stretch of hamstring muscle

The patient was asked to flex his hip joint with complete knee extension and ankle in neutral position. The therapist stretches the hamstring of the dominant side; distal hand of the therapist on planter surface of foot for dorsiflexion. and proximal hand on the knee to increase the length of the muscle, maintain this stretching for 60 seconds then relax .Sub occipital muscle inhibition:

The Patient is supine, The therapist stretch the sub occipital, flexes the head of the patient to get the chin to the manibiurim sternii, maintaining this position for 60seconds then relax Slump strtch position:Patient in comfortable short sitting position at the edge of the bed with the trunk in an millitary straight position then ask the patient to slump the flex his neck and street the knee joint in complete extension the at the end of the procedure do active dorsiflexion at the tested foot

Other Names:
  • slump stretch position
  • Passive stretch of the hamstring muscle.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Straight leg raising test
Time Frame: after 4 weeks of intervention.
the patient was supine lying position with hip and knee extension at the starting position, then the patient was asked to actively flex hip joint as much as possible while maintaining the knee in extension position. Then with the goniometer the therapist started to determine the angle of hip flexion, patients were excluded if the SRL was more than 80˚at the initial evaluation
after 4 weeks of intervention.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Popliteal Angle Test
Time Frame: after 4 weeks of intervention.
while the patient was in supine line position, the hip and knee joint was flexed to 90˚ then the patient was asked to extend the knee joint as much as possible with maintaining the hip in flexion 90˚. Then with the goniometer the therapist determines the angle of the knee flexion, subjects were excluded if their angle of flexion less than 15 ˚
after 4 weeks of intervention.
Forward flexion test
Time Frame: after 4 weeks of treatment.
the patient was stride standing on footstep facing the therapist and then asked to flex her trunk with his hands facing forward, maintaining the knee in extended position. The therapist then measures the distance between the middle finger and the ground while the trunk is in complete flexion.
after 4 weeks of treatment.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Hadaya M El Adl, Phd, Jouf University, Collage of applied medical science.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2019

Primary Completion (Actual)

December 30, 2019

Study Completion (Actual)

December 30, 2019

Study Registration Dates

First Submitted

January 22, 2020

First Submitted That Met QC Criteria

January 25, 2020

First Posted (Actual)

January 28, 2020

Study Record Updates

Last Update Posted (Actual)

January 28, 2020

Last Update Submitted That Met QC Criteria

January 25, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P.T.REC/012/002566

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Informed consent form, Study protocol

IPD Sharing Time Frame

we will share results after 6 months of publication.

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Informed Consent Form (ICF)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Diseases or Conditions

Clinical Trials on Suboccipital muscle inhibition

3
Subscribe